Table 1. Individual pharmacokinetic parameters of TQD after single dose administration at doses of 4, 6 and 8 mg/kg BW (n=5 per dose group).
| Dose group (mg/kg BW) |
Subject number |
Infusion duration (h) |
Dose (mg) |
Cmax (mg/l) |
tmax(h) | AUC0-n (mg*h/l) |
CL (l/h) | t½(h) | Vss (l) |
|---|---|---|---|---|---|---|---|---|---|
| 4 | 1 | 1.72 | 388 | 1.31 | 1.29 | 14.48 | 9.27 | 43 | 558 |
| 4 | 2 | 1.38 | 312 | 1.21 | 1.38 | 11.39 | 11.29 | 33 | 530 |
| 4 | 3 | 1.45 | 328 | 1.12 | 1.45 | 12.71 | 7.39 | 55 | 571 |
| 4 | 4 | 1.55 | 348 | 1.47 | 1.55 | 17.26 | 9.22 | 30 | 384 |
| 4 | 5 | 1.40 | 316 | 1.13 | 1.40 | 13.54 | 10.11 | 31 | 445 |
| 6 | 6 | 1.83 | 414 | 2.03 | 1.83 | 19.96 | 13.53 | 16 | 312 |
| 6 | 7 | 2.23 | 504 | 1.81 | 2.23 | 18.00 | 11.35 | 35 | 559 |
| 6 | 8 | 2.80 | 630 | 1.13 | 2.80 | 19.68 | 13.56 | 34 | 645 |
| 6 | 9 | 2.45 | 552 | 1.64 | 2.45 | 20.12 | 13.99 | 26 | 509 |
| 6 | 10 | 2.45 | 552 | 1.31 | 2.45 | 16.16 | 15.15 | 33 | 680 |
| 8 | 11 | 2.82 | 632 | 1.59 | 2.82 | 23.61 | 15.71 | 21 | 453 |
| 8 | 12 | 2.42 | 544 | 1.92 | 2.42 | 18.83 | 15.41 | 25 | 521 |
| 8 | 13 | 2.28 | 512 | 1.05 | 2.28 | 14.77 | 16.21 | 30 | 667 |
| 8 | 14 | 2.70 | 608 | 1.87 | 2.70 | 21.81 | 20.85 | 14 | 380 |
| 8 | 15 | 2.67 | 604 | 1.66 | 2.26 | 16.64 | 22.15 | 21 | 616 |